bioAffinity Technologies BIAF Cash Flow Statement (2021-2026)

NASDAQ BIAF
$5.10 +0.02 (+0.39%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

bioAffinity Technologies Quarterly Cash Flow Statement

Periods 20 quarters
Latest Jun 2026

bioAffinity Technologies reported cash from operations of -$3.20M and free cash flow of -$3.29M for the quarter ended Jun 2026, down 20.9% year over year. This cash flow statement covers 20 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -1.51M-5.58M-1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-1.06M-2.66M-4.06M-5.05M29.80M-3.63M-3.37M
Share-based CompensationStock Comp. -0.02M-89.52M0.11M0.03M1.10M0.04M1.10M2.00M0.68M0.49M2.00M2.00M2.00M0.23M2.00M2.00M0.07M0.07M0.07M1.00M
Gains from Investment SecuritiesGains Investment 2.75M
Cash from OperationsCash from Ops. -0.65M-0.63M-0.38M-1.76M-1.30M-1.53M-1.36M-1.53M-1.62M-2.35M-1.53M-1.71M-1.68M-1.64M-2.65M-2.48M-2.56M-3.23M-3.20M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles 0.98M0.23M0.77M0.08M
Depreciation & Amortization (CF)Dep. & Amort. 794.000.00M0.00M773.000.01M0.02M0.02M0.06M0.15M0.15M0.15M0.15M0.15M0.15M0.11M0.11M0.12M0.11M0.06M
Change in Working Capital
Change in ReceivablesChange Receivables 0.01M956.000.00M559.00538.000.08M-0.15M-0.24M0.31M0.47M-0.27M-0.19M-0.18M-0.54M0.03M0.09M0.14M0.21M
Change in InventoryChange Inventory 0.01M-146.0058.00-175.000.01M-0.00M-193.000.01M-0.01M0.02M-0.00M0.00M0.01M0.01M-0.01M0.02M0.02M0.00M
Change in Account PayablesChange Payables -0.03M0.02M0.34M-0.44M0.20M-0.20M0.03M0.58M-0.42M-0.22M0.46M-0.07M0.20M0.39M-0.21M-0.23M-0.18M0.07M0.13M
Change in Accured ExpensesChange Accured Exp. 0.16M0.17M0.17M0.13M-0.03M-0.06M0.03M-0.12M0.51M-0.27M0.09M-0.06M0.49M-0.03M-0.32M-0.06M0.73M0.31M-0.61M
Investing Activities
Capital ExpendituresCapex 0.03M0.00M169.00-0.01M0.04M0.03M0.01M1.000.05M0.01M-0.00M1.000.01M0.09M
Cash from Investing ActivitiesCash from Investing -0.03M-0.00M-2.19M0.01M-0.04M-0.03M-0.01M-1.00-0.05M-0.01M0.00M-1.00-0.01M-0.09M
Financing Activities
Other financing activitiesOther financing 2.00M2.66M1.17M1.63M6.47M1.80M3.20M
Cash from Financing ActivitiesCash from Financing 1.77M0.30M-0.44M15.04M-0.56M-0.08M-0.13M-0.05M-0.08M2.02M-0.09M1.67M2.03M1.03M3.02M9.34M1.34M-0.12M2.62M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued 0.08M0.01M0.01M0.06M0.12M0.20M0.35M0.19M0.06M0.06M
Additional items
Change in Cash 1.12M-0.33M-0.81M13.28M-2.08M-1.64M-1.49M-3.77M-1.69M-0.37M-1.65M-0.04M0.35M-0.66M0.36M6.87M-1.22M-3.35M-0.67M
Free Cash FlowFCF -0.65M-0.63M-0.38M-1.76M-1.30M-1.56M-1.36M-1.53M-1.60M-2.39M-1.56M-1.72M-1.68M-1.69M-2.66M-2.48M-2.56M-3.23M-3.29M
Net Cash FlowNCF 1.12M-0.33M-0.81M13.28M-1.86M-1.64M-1.49M-3.77M-1.69M-0.37M-1.65M-0.04M0.35M-0.66M0.36M6.87M-1.22M-3.35M-0.67M